© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome*
aDepartment of Medical Physiology, Utrecht University, Utrecht, The Netherlands
bDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands
cDepartment of Experimental and Molecular Cardiology, Academic Medical Center, Amsterdam, The Netherlands
dDepartment of Physiology, Academic Medical Center, Amsterdam, The Netherlands
eHeart Lung Institute, University Hospital Utrecht, Utrecht, The Netherlands
fDepartment of Cardiology, University Hospital Groningen, Groningen, The Netherlands
gLaboratory of Molecular Genetics, Department of Pathology, The Medical School, University of Malta, Msida, Malta
hThe Interuniversity Cardiology Institute of The Netherlands
* Corresponding author. Academic Medical Center, University of Amsterdam, Department of Clinical and Experimental Cardiology, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Tel.: +31-20-566-3265; fax: +31-20-697-5458 c.alshinawi{at}amc.uva.nl
Background: Primary dysrhythmias other than those associated with the long QT syndrome, are increasingly recognized. One of these are represented by patients with a history of resuscitation from cardiac arrest but without any structural heart disease. These patients exhibit a distinct electrocardiographic (ECG) pattern consisting of a persistent ST-segment elevation in the right precordial leads often but not always accompanied by a right bundle branch block (Brugada syndrome). This syndrome is associated with a high mortality rate and has been shown to display familial occurrence. Methods and results: Pharmacological sodium channel blockade elicits or worsens the electrocardiographic features associated with this syndrome. Hence, a candidate gene approach directed towards SCN5A, the gene encoding the 
-subunit of the cardiac sodium channel, was followed in six affected individuals. In two patients missense mutations were identified in the coding region of the gene: R1512W in the DIII–DIV cytoplasmic linker and A1924T in the C-terminal cytoplasmic domain. In two other patients mutations were detected near intron/exon junctions. To assess the functional consequences of the R1512W and A1924T mutations, wild-type and mutant sodium channel proteins were expressed in Xenopus oocytes. Both missense mutations affected channel function, most notably a 4–5 mV negative voltage shift of the steady-state activation and inactivation curves in R1512W and a 9 mV negative voltage shift of the steady-state activation curve in A1924T, measured at 22°C. Recovery from inactivation was slightly prolonged for R1512W channels. The time dependent kinetics of activation and inactivation at –20 mV were not significantly affected by either mutation. Conclusions: Two SCN5A mutations associated with the Brugada syndrome, significantly affect cardiac sodium channel characteristics. The alterations seem to be associated with an increase in inward sodium current during the action potential upstroke.
KEYWORDS Ventricular arrhythmias; Sudden death; Ion channels; Genetic code
* M.B.R. and C.B.A. contributed equally to this work.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B R Anderson and V L Vetter Return to play? Practical considerations for young athletes with cardiovascular disease Br. J. Sports Med., September 1, 2009; 43(9): 690 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Babai Bigi, A. Aslani, and S. Shahrzad Clinical predictors of atrial fibrillation in Brugada syndrome Europace, October 1, 2007; 9(10): 947 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zona, M. Pieri, and I. Carunchio Voltage-Dependent Sodium Channels in Spinal Cord Motor Neurons Display Rapid Recovery From Fast Inactivation in a Mouse Model of Amyotrophic Lateral Sclerosis J Neurophysiol, December 1, 2006; 96(6): 3314 - 3322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Rossenbacker, E Schollen, C Kuiperi, T J L de Ravel, K Devriendt, G Matthijs, D Collen, H Heidbuchel, and P Carmeliet Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy J. Med. Genet., May 1, 2005; 42(5): e29 - e29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, S. Ghosh, H. Liu, M. Tateyama, R. S. Kass, and G. S. Pitt Calmodulin Mediates Ca2+ Sensitivity of Sodium Channels J. Biol. Chem., October 22, 2004; 279(43): 45004 - 45012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Gibbons, C. C. Liew, M. O. Goodarzi, J. I. Rotter, W. A. Hsueh, H. M. Siragy, R. Pratt, and V. J. Dzau Genetic Markers: Progress and Potential for Cardiovascular Disease Circulation, June 29, 2004; 109(25_suppl_1): IV-47 - IV-58. [Full Text] [PDF]
|
|
|
|
 |
|
 H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde Genetic control of sodium channel function Cardiovasc Res, March 15, 2003; 57(4): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.A. Groenewegen, C. R. Bezzina, J.P. van Tintelen, T. M. Hoorntje, M. M.A.M. Mannens, A. A.M. Wilde, Habo.J. Jongsma, and M. B. Rook A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics Cardiovasc Res, March 15, 2003; 57(4): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Bezzina, M. B. Rook, W.A. Groenewegen, L. J. Herfst, A. C. van der Wal, J. Lam, H. J. Jongsma, A. A.M. Wilde, and M. M.A.M. Mannens Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System Circ. Res., February 7, 2003; 92(2): 159 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Groenewegen, M. Firouzi, C. R. Bezzina, S. Vliex, I. M. van Langen, L. Sandkuijl, J. P.P. Smits, M. Hulsbeek, M. B. Rook, H. J. Jongsma, et al. A Cardiac Sodium Channel Mutation Cosegregates With a Rare Connexin40 Genotype in Familial Atrial Standstill Circ. Res., January 10, 2003; 92(1): 14 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Moric, E. Herbert, M. Trusz-Gluza, A. Filipecki, U. Mazurek, and T. Wilczok The implications of genetic mutations in the sodium channel gene (SCN5A) Europace, January 1, 2003; 5(4): 325 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Edge, D. J. Blackman, K. Gupta, and M. Sainsbury General anaesthesia in a patient with Brugada syndrome Br. J. Anaesth., November 1, 2002; 89(5): 788 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Morita, K. Kusano-Fukushima, S. Nagase, Y. Fujimoto, K. Hisamatsu, H. Fujio, K. Haraoka, M. Kobayashi, S. T. Morita, K. Nakamura, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1437 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch Late potentials and the Brugada syndrome J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1996 - 1999. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Balser Inherited sodium channelopathies: models for acquired arrhythmias? Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1175 - H1180. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vatta, R. Dumaine, G. Varghese, T. A. Richard, W. Shimizu, N. Aihara, K. Nademanee, R. Brugada, J. Brugada, G. Veerakul, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome Hum. Mol. Genet., February 1, 2002; 11(3): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Antzelevitch The Brugada syndrome: diagnostic criteria and cellular mechanisms Eur. Heart J., March 1, 2001; 22(5): 356 - 363. [PDF]
|
|
|
|
|
|
C.A Remme, E.F.D Wever, A.A.M Wilde, R Derksen, and R.N.W Hauer Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation Eur. Heart J., March 1, 2001; 22(5): 400 - 409. [Abstract] [PDF]
|
|
|
|
|
|
C. R Bezzina, M. B Rook, and A. A.M Wilde Cardiac sodium channel and inherited arrhythmia syndromes Cardiovasc Res, February 1, 2001; 49(2): 257 - 271. [Full Text] [PDF]
|
|
|
|
|
|
X. Wan, S. Chen, A. Sadeghpour, Q. Wang, and G. E. Kirsch Accelerated inactivation in a mutant Na+ channel associated with idiopathic ventricular fibrillation Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H354 - H360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Wang, N. Makita, A. Kitabatake, J. R. Balser, and A. L. George Jr Enhanced Na+ Channel Intermediate Inactivation in Brugada Syndrome Circ. Res., October 13, 2000; 87 (8): e37 - e43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A.M. Wilde and M. W. Veldkamp What we can learn from individual resuscitated patients Cardiovasc Res, April 1, 2000; 46(1): 14 - 16. [Full Text] [PDF]
|
|
|
|
|
|
I. Rivolta, H. Abriel, M. Tateyama, H. Liu, M. Memmi, P. Vardas, C. Napolitano, S. G. Priori, and R. S. Kass Inherited Brugada and Long QT-3 Syndrome Mutations of a Single Residue of the Cardiac Sodium Channel Confer Distinct Channel and Clinical Phenotypes J. Biol. Chem., August 10, 2001; 276(33): 30623 - 30630. [Abstract] [Full Text] [PDF]
|
|